Photo: Hadassah Medical Organization

Photo: Hadassah Medical Organization

Researchers at Hadassah Medical Center in Jerusalem have found a way to treat and prevent the deterioration of retinas using human embryonic stem cells (hESCs). While the research was based on animal models, the researchers believe that this breakthrough may lead to a possible cure for age related macular degeneration (AMD), a disease affecting almost 2 percent of the American population over 40.

In a paper published this month in Cell-Stem Cell magazine, Prof. Benjamin Reubinoff, Director of the Hadassah Human Embryonic Stem Cell Research Center, and Prof. Eyal Banin, Director of the Hadassah Center for Retinal and Macular Degeneration, transplanted pigment-containing visual cells derived from hESCs in animals exhibiting macular degeneration. After the transplant, researchers observed that the cells manged to successfully preserve the structure and function of the specialized light-sensitive lining of the eye.

“Although there are a variety of therapeutic approaches under development to delay the degenerative process, the grim reality is that many patients eventually lose their sight,” explains Dr. Reubinoff. “Cell therapy, which can replenish the degenerating RPE cells, may potentially halt disease progression.”

AMD is characterized  by dysfunction of the retinal pigment epithelium (RPE), a layer of cells underlying and supporting the retina, which leads to damage in the central area of the retina known as the macula. The macula is responsible for high resolution vision, and is crucial for activities such as reading, driving, watching television and recognizing faces. This cutting edge work is an important step toward the future use of hESCs to treat degenerative eye diseases such as age-related macular degeneration, which causes millions of people worldwide to lose their sight.

“Our findings are an important step towards the potential future use of human embryonic stem cells to support and replenish failing RPE cells in diseases that result in blindness,” Prof. Banin stated.

The next step in this research is now transfering the knowledge gained in animal models to human clinical trials.

4 people like this post.
Share and Enjoy:
  • Print
  • email
  • Digg
  • del.icio.us
  • Facebook
  • Google Bookmarks
  • Ping.fm
  • FriendFeed
  • Technorati

Related Posts: